These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2149648)

  • 1. Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.
    Maier W; Albus M; Buller R; Nutzinger D; Shera D; Bech P
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):103-8. PubMed ID: 2149648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.
    Albus M; Maier W; Shera D; Bech P
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):96-102. PubMed ID: 2149655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S; Rosenberg NK; Kullingsjö H; Ottosson JO; Bech P; Bruun-Hansen J; Hanson L; Lorentzen K; Mellergård M; Rasmussen S
    Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of panic disorder patients responding to placebo.
    Rosenberg NK; Mellergård M; Rosenberg R; Beck P; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():33-8. PubMed ID: 1862732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M; Lorentzen K; Bech P; Ottosson JO; Rosenberg R
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of response during placebo treatment of panic disorder.
    Mellergård M; Rosenberg NK
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
    Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M; Lecrubier Y; Maier W; Buller R; Rosenberg R; Hippius H
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R; Maier W; Goldenberg IM; Lavori PW; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(3):163-8. PubMed ID: 1827602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surreptitious drug use by patients in a panic disorder study.
    Clark DB; Taylor CB; Roth WT; Hayward C; Ehlers A; Margraf J; Agras WS
    Am J Psychiatry; 1990 Apr; 147(4):507-9. PubMed ID: 1969248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.